| Entry |
|
|---|
| Name |
Cidofovir (USAN/INN);
Cidofovir dihydrate;
Vistide (TN)
|
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C8H14N3O6P. 2H2O
|
|---|
| Exact mass |
315.0832
|
|---|
| Mol weight |
315.2176
|
|---|
| Structure |
     |
|---|
| Activity |
|
|---|
| Remark |
|
|---|
| Target |
DNA polymerase inhibitor [EC: 2.7.7.7] |
|---|
| Metabolism |
Transporter: SLC22A6 [HSA: 9356]
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB12 Cidofovir
D00273 Cidofovir (USAN/INN)
USP drug classification [BR:br08302]
Antivirals
Anti-cytomegalovirus (CMV) Agents
Cidofovir
D00273 Cidofovir (USAN/INN)
Antiinfectives [BR:br08307]
Antivirals
Anti-CMV agent
DNA polymerase inhibitor
Nucleotide analogue
Cidofovir [ATC:J05AB12]
D00273 Cidofovir (USAN/INN)
 |
|---|
| Other DBs |
CAS: 149394-66-1 PubChem: DrugBank: LigandBox: |
|---|
| KCF data |
ATOM 20
1 N4y N 23.6599 -16.9347
2 C1b C 23.6730 -18.2848
3 C8y C 24.8784 -16.2228
4 C8x C 22.4470 -16.2256
5 C1c C 22.4544 -18.9966
6 N5x N 24.8654 -14.8727
7 O5x O 26.0214 -16.9319
8 C8x C 22.5039 -14.8755
9 O2a O 21.2415 -18.2875
10 C1b C 22.5029 -20.2861
11 C8y C 23.6525 -14.1636
12 C1b C 20.1284 -18.9388
13 N1a N 23.6739 -12.8742
14 P1b P 18.9155 -18.2297
15 O1c O 18.1354 -19.5639
16 O1c O 17.5206 -17.4142
17 O1c O 19.7664 -16.7741
18 O1a O 23.6310 -20.9667
19 O0 O 29.0884 -19.5232
20 O0 O 29.0884 -19.5232
BOND 18
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 1
6 3 7 2
7 4 8 2
8 5 9 1
9 5 10 1
10 6 11 2
11 9 12 1
12 11 13 1
13 12 14 1
14 14 15 1
15 14 16 1
16 14 17 2
17 8 11 1
18 10 18 1
BRACKET 1 27.0900 -20.3700 27.0900 -18.3400
1 29.5400 -18.3400 29.5400 -20.3700
1 2
ORIGINAL 1 19
REPEAT 1 20
|
|---|
